At the news
? NEUTRALIMPACT 4/10 8-K filed May 6, 2026 at 16:01 ET
Lexicon Pharmaceuticals entered into a $100 million loan facility with Hercules Capital, with $55 million funded at closing to repay existing debt. The facility provides non-dilutive capital with an 18-month interest-only period (extendable to 30 months upon milestones) and matures in May 2030. Warrants for 691,823 shares were issued to Hercules, representing modest dilution.
- Loan facility of up to $100 million from Hercules Capital, $55 million funded at closing
- Funds used to repay existing Oxford Finance loan
- Interest rate: prime rate + 3.10%, floor 9.85%
- Interest-only period: 18 months, extendable to 30 months upon clinical/regulatory milestones
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access